Goodwin Procter and Dechert advised Relay Therapeutics, Inc. in the offering, and Ropes & Gray advised the underwriters.Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
